202 related articles for article (PubMed ID: 33509093)
1. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist.
Li Q; Liu W; Gao S; Mao Y; Xin Y
BMC Immunol; 2021 Jan; 22(1):11. PubMed ID: 33509093
[TBL] [Abstract][Full Text] [Related]
2. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model.
Shobeiri SS; Rezaee M; Pordel S; Haghnnavaz N; Dashti M; Moghadam M; Sankian M
Int Immunopharmacol; 2022 Sep; 110():108963. PubMed ID: 35724603
[TBL] [Abstract][Full Text] [Related]
4. Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model.
Al-Harbi NO; Nadeem A; Al-Harbi MM; Zoheir KMA; Ansari MA; El-Sherbeeny AM; Alanazi KM; Alotaibi MR; Ahmad SF
Immunobiology; 2017 Feb; 222(2):128-136. PubMed ID: 27773660
[TBL] [Abstract][Full Text] [Related]
5. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.
Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L
Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
8. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
12.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
13. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod-induced ex vivo model of psoriatic human skin via interleukin-17A signalling of T cells and Langerhans cells.
Carlos ECDS; Cristovão GA; Silva AA; Ribeiro BCS; Romana-Souza B
Exp Dermatol; 2022 Nov; 31(11):1791-1799. PubMed ID: 36054147
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
[TBL] [Abstract][Full Text] [Related]
18. Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice.
Chen HH; Lin CC; Tung YT; Chao YH; Huang WC; Lee PY
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316255
[TBL] [Abstract][Full Text] [Related]
19. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
20. Notch1/Hes1‑PTEN/AKT/IL‑17A feedback loop regulates Th17 cell differentiation in mouse psoriasis‑like skin inflammation.
Lin YW; Li XX; Fu FH; Liu B; Xing X; Qi R; Ma L
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35582997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
